Application
IHC-P analysis of rectum cancer tissues using p38 MAPK antibody [8G4D11].Application
IHC-P analysis of cervical cancer tissues using p38 MAPK antibody [8G4D11].Application
FACS analysis of HeLa cells using p38 MAPK antibody [8G4D11] (green) or a negative control (red).Application
ICC/IF analysis of HeLa cells using p38 MAPK antibody [8G4D11] (green), Alexa Fluor-555 phalloidin (red) and DRAQ5 fluorescent DNA dye (blue).Application
ELISA analysis of control antigen and antigen using p38 MAPK antibody [8G4D11].Application
WB analysis of lysates from (1) untransfected and (2) MAPK14 (a.a. 299-360)-hIgGFc transfected HEK293 cells using p38 MAPK antibody [8G4D11].Application
WB analysis of (1) HeLa, (2) NIH3T3, (3) Jurkat, Raw264.7 (4), (5) PC-12, (6) C6 and (7) COS7 lysates using p38 MAPK antibody [8G4D11].Application
WB analysis of human MAPK14 recombinant protein using p38 MAPK antibody [8G4D11].| Product Name | p38 MAPK antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Product description | Mouse monoclonal antibody [8G4D11] to p38 MAPKThe protein encoded by this gene is a member of the MAP kinase family. MAP kinases act as an integration point for multiple biochemical signals, and are involved in a wide variety of cellular processes such as proliferation, differentiation, transcription regulation and development. This kinase is activated by various environmental stresses and proinflammatory cytokines. The activation requires its phosphorylation by MAP kinase kinases (MKKs), or its autophosphorylation triggered by the interaction of MAP3K7IP1/TAB1 protein with this kinase. The substrates of this kinase include transcription regulator ATF2, MEF2C, and MAX, cell cycle regulator CDC25B, and tumor suppressor p53, which suggest the roles of this kinase in stress related transcription and cell cycle regulation, as well as in genotoxic stress response. Four alternatively spliced transcript variants of this gene encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008] |
| Immunogen | The immunogen corresponding to a region within amino acids 299 and 360 of human MAPK14 expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Isotype | IgG1 |
| Clone Number | 8G4D11 |
| Host Species | Mouse |
| Tested Applications | ELISAFACSICC/IFIHCIHC-PWB |
| ELISA: 1/10000.: |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml (Please refer to the vial label for the specific concentration) |
| Gene Synonyms | CSBP MXI2 CSPB1 MAPK14 CSBP2 P38ALPHA SAPK2A PRKM14 CSBP1 P38 PRKM15 RK EXIP |
|---|---|
| Target | p38 MAPK |
| Molecular Weight(MW) | 41.3 kDa (note) |
Application
IHC-P analysis of rectum cancer tissues using p38 MAPK antibody [8G4D11].
Application
IHC-P analysis of cervical cancer tissues using p38 MAPK antibody [8G4D11].
Application
FACS analysis of HeLa cells using p38 MAPK antibody [8G4D11] (green) or a negative control (red).
Application
ICC/IF analysis of HeLa cells using p38 MAPK antibody [8G4D11] (green), Alexa Fluor-555 phalloidin (red) and DRAQ5 fluorescent DNA dye (blue).
Application
ELISA analysis of control antigen and antigen using p38 MAPK antibody [8G4D11].
Application
WB analysis of lysates from (1) untransfected and (2) MAPK14 (a.a. 299-360)-hIgGFc transfected HEK293 cells using p38 MAPK antibody [8G4D11].
Application
WB analysis of (1) HeLa, (2) NIH3T3, (3) Jurkat, Raw264.7 (4), (5) PC-12, (6) C6 and (7) COS7 lysates using p38 MAPK antibody [8G4D11].
Application
WB analysis of human MAPK14 recombinant protein using p38 MAPK antibody [8G4D11].| Application Notes | ELISA: 1/10000.: |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | 4°C; -20°C for long term storage |
| Storage Buffer | Purified antibody in PBS with 0.05% sodium azide and 0.5% protein stabilizer. |
